Answers are grounded in this paper and cite their sources.
BACKGROUND: Lung cancer (LC) and pulmonary tuberculosis (PTB) often occur simultaneously and pose significant clinical challenges. This study investigated the common risk factors and mechanisms underlying this comorbidity. MATERIALS AND METHODS: In this retrospective study, data from 1275 patients at Masih Daneshvari Hospital were reviewed between 2011 and 2024. Of these, 38 patients had LC-PTB comorbidity and 1237 patients had LC without mycobacterial infection. Data on demographic characteristics, smoking status, tumor type, and disease stage were collected and analyzed. RESULTS: The mean age was 58.46 years, with 72.94% males and 54.51% of smokers. Adenocarcinoma (26.12%) and squamous-cell carcinoma (21.73%) were the most common tumor types, and stage IV disease was predominant (80.94%). No significant differences were observed in tumor characteristics or disease stage between the LC-PTB and LC-only groups ( P > 0.05). Smoking correlated with older age ( P < 0.05). CONCLUSION: This study identifies key characteristics of LC-PTB comorbidity, highlighting a high proportion of advanced-stage diagnoses and the absence of significant differences in tumor characteristics between LC-PTB and LC-only patients within this cohort. These findings underscore the need for heightened surveillance and screening protocols in individuals with a history of TB to enable earlier detection of LC. Further research, employing multi-center data and advanced molecular techniques, is essential to elucidate the underlying mechanisms driving this comorbidity and to develop targeted diagnostic and therapeutic interventions, ultimately improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Khosravi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: